Archives
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
Novobiocin, DNA Replication, and E. faecalis Protoplasts
2026-09-15
This study shows that DNA replication is linked to plasma membrane synthesis and vacuole formation during enlargement of Enterococcus faecalis protoplasts. By applying novobiocin at defined stages and tracking DNA content, cell size, and vacuoles, the authors identify a reversible replication-dependent control point in bacterial morphogenesis.
BicD and MAP7 Activate Drosophila Kinesin-1
2026-09-14
This 2025 bioRxiv preprint shows that BicD and MAP7 activate homodimeric Drosophila kinesin-1 through complementary mechanisms. BicD primarily relieves kinesin autoinhibition, whereas MAP7 promotes microtubule recruitment and longer runs, producing the strongest activation when both regulators are present.
Smg5–Hnrnpl–Mag Control of Oligodendrocyte Maturation
2026-09-14
The reference study identifies an Smg5-dependent nonsense-mediated mRNA decay pathway that controls oligodendrocyte differentiation through selective regulation of Hnrnpl variant transcripts. Its findings connect RNA surveillance with HNRNPL-dependent alternative splicing of Mag and Nfasc, providing a mechanistic framework for understanding CNS myelination and its functional consequences.
DOT1L Inhibition in Renal Fibrosis: Study Insights
2026-09-13
The reference study identifies DOT1L-dependent H3K79 methylation as a modifiable regulator of renal fibroblast activation and epithelial–mesenchymal transition after obstructive kidney injury. By combining a selective inhibitor, DOT1L silencing, cultured renal cells, and a murine unilateral ureteral obstruction model, it provides a mechanistic basis for investigating epigenetic control of renal fibrosis.
InstaBlue Protein Stain Solution: Assay Design
2026-09-12
InstaBlue Protein Stain Solution can turn rapid gel staining into a more deliberate analytical decision point. This article connects Coomassie-based visualization with PRMT6-mediated antiviral research, clarifying what a stained gel can prove, what it cannot, and how to preserve samples for downstream analysis.
Fast-Dissociating Antibodies from Hybridoma Cultures
2026-09-12
Miyoshi et al. developed a semi-automated single-molecule TIRF assay that identifies specific, fast-dissociating monoclonal antibodies directly from hybridoma cultures. The resulting Fab probes enabled multiplex super-resolution imaging and revealed rapid espin turnover within long-lived actin cores of inner-ear hair-cell stereocilia.
DPF2 Splicing Rewires Stem and Neuronal Programs
2026-09-11
The reference study shows that PTBP1-directed alternative splicing changes the DPF2 subunit of BAF chromatin-remodeling complexes during neuronal differentiation. Its findings connect an RNA-processing switch to isoform-specific chromatin occupancy, transcription-factor associations, and developmental gene regulation.
CARMIL Membrane Binding Controls Actin Assembly
2026-09-11
Mooren and colleagues show that the CARMIL membrane-binding domain is an active regulator of capping protein, not merely a membrane tether. Their biochemical results explain how CARMIL can recruit capping protein to lipid surfaces, promote localized actin assembly, and then release from the membrane after capping protein engagement.
Lithium, Exosomal Wnt10a, and Bone Regeneration
2026-09-10
The 2024 ACS Applied Materials & Interfaces study shows that lithium enhances BMSC osteogenesis by promoting Rab11a/Rab11FIP1-dependent trafficking and secretion of exosomal Wnt10a, thereby activating β-catenin signaling. Lithium-conditioned exosomes and GelMA formulations improved osteogenic differentiation and bone repair, providing a mechanistic basis for engineering exosome-based regenerative therapies.
Protease Inhibitor Cocktail for MS Proteomics
2026-09-10
Discover how a Protease Inhibitor Cocktail can preserve fragile signaling proteins during extraction and MS proteomics. This article uses CYR61–migrasome biology to explain assay decisions beyond routine protein degradation prevention.
TBXA2R–ERM Signaling in TNBC Metastasis
2026-09-09
Leguay et al. identify TBXA2R as an upstream GPCR that activates ezrin, radixin, and moesin through Gαq/11, Gα12/13, Rho GTPases, SLK, and LOK. The resulting TBXA2R–ERM axis connects receptor signaling to triple-negative breast cancer motility, invasion, and metastatic colonization, providing a mechanistic framework for studying GPCR-controlled cytoskeletal remodeling.
Mdivi-1: Selective DRP1 Inhibitor Guide
2026-09-09
Mdivi-1 is a cell-permeable selective DRP1 inhibitor used to investigate mitochondrial fission, apoptosis, and neuroprotection. Its effects should be interpreted with orthogonal readouts because published evidence also identifies mitochondrial complex I inhibition as a potential confounder.
MCL-1 Dependence in Breast Cancer: Study Insights
2026-09-08
The reference study shows that established breast tumors depend on MCL-1 primarily because of its canonical anti-apoptotic activity, rather than because of an independent non-apoptotic function. By combining genetic deletion, pharmacological inhibition, BAX/BAK epistasis, and stem-cell analyses, the work clarifies how MCL-1 targeting can be interpreted in breast cancer research.
Epacadostat: IDO1 Control in Whole-Blood Assays
2026-09-07
Epacadostat (INCB024360) provides a precise way to interrogate IDO1-dependent tryptophan metabolism in immuno-oncology research. This guide shows how to integrate the compound with standardized whole-blood stimulation while separating enzyme inhibition from broader immunometabolic effects.
BCA Protein Quantification Kit K4102
2026-09-07
The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 provides sensitive total-protein measurement for dilute samples, including many detergent-containing biochemical preparations and cell lysates. It is intended for scientific research workflows such as sample normalization and is not for diagnostic, clinical, or medical use.